retatrutide update october 2025 Phase III study demonstrates 30% weight loss Retatrutide Dosing Guide: 1-12 mg

Energy + Mood Energy + Mood Energy + Mood Energy + Mood Energy + Mood Energy + Mood Energy + Mood Energy + Mood Premium GLP-1/GIP + B12 blend featuring a full dose of Personalized GLP-1/GIP, enhanced with B Vitamins to regulate blood sugar levels resulting to weight loss and boosting energy levels

In contrast, Ozempic first received FDA approval in 2017 for Type 2 diabetes

But in Australia, cautious medical regulators and global supply shortages, which began in 2022 and are expected to continue through 2024, have limited the extent to which the drugs are available

More recently, the buzz is around a new trend: micro-dosing these medications

Williams Endowed Chair and Professor of Medicine at the University of Washington, speaks with Areesha Moiz about how GLP-1 receptor agonists reshape obesity treatment